|
Page: Vaccination
Main article
| Home > Child Health > Vaccination |
All current vaccines target only bacterial meningitis.
Vaccinations against Haemophilus influenzae (Hib) have decreased early childhood meningitis significantly.
Vaccines against type A and C Neisseria meningitidis, the kind that causes most disease in preschool children and teenagers in the United States, have also been around for a while. Type A is also prevalent in sub-Sahara Africa and W135 outbreaks have affected those on the Hajj pilgrimage to Mecca.
A vaccine called MeNZB for a specific strain of type B Neisseria meningitidis prevalent in New Zealand has completed trials and is being given to many people in the country under the age of 20. There is also a vaccine, MenBVac, for the specific strain of type B meningoccocal disease prevalent in Norway, and another specific vaccine for the strain prevalent in Cuba.
Pneumovax (also known as Prevenar) against Streptococcus pneumoniae is recommended for all people 65 years of age or older. and for all newborns starting at 6 weeks - 2 months, according to American Association of Pediatrics (AAP) recommendations.
|
Important notice:
The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other
qualified health provider with any questions you may have regarding a medical condition.
|